MiNK Therapeutics, Inc. Banner Image

MiNK Therapeutics, Inc.

  • Ticker INKT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
MiNK Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducibleMore manufacturing for off-the-shelf delivery. The company is headquartered in New York, New York.
MiNK Therapeutics, Inc.

Most Recent Annual Report

MiNK Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

MiNK Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!